Nihon Kohden (OTCMKTS:NHNKY) & Adagio Medical (NASDAQ:ADGM) Head-To-Head Survey

Adagio Medical (NASDAQ:ADGM) and Nihon Kohden (OTCMKTS:NHNKY) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations and institutional ownership.

Volatility & Risk

Adagio Medical has a beta of 0.13, suggesting that its stock price is 87% less volatile than the S&P 500. Comparatively, Nihon Kohden has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500.

Valuation & Earnings

This table compares Adagio Medical and Nihon Kohden”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	$600,000.00	23.30	-$75.04 million	($1.52)	-0.60
Nihon Kohden	$1.48 billion	1.33	$93.05 million	$0.73	15.75

Nihon Kohden has higher revenue and earnings than Adagio Medical. Adagio Medical is trading at a lower price-to-earnings ratio than Nihon Kohden, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Adagio Medical and Nihon Kohden’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-791.01%	-199.58%
Nihon Kohden	7.78%	9.28%	6.60%

Analyst Ratings

This is a summary of recent recommendations and price targets for Adagio Medical and Nihon Kohden, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1	0	1	0	2.00
Nihon Kohden	0	0	0	0	0.00

Adagio Medical presently has a consensus target price of $4.00, suggesting a potential upside of 340.04%. Given Adagio Medical’s stronger consensus rating and higher possible upside, research analysts clearly believe Adagio Medical is more favorable than Nihon Kohden.

Insider & Institutional Ownership

48.1% of Adagio Medical shares are owned by institutional investors. Comparatively, 0.1% of Nihon Kohden shares are owned by institutional investors. 5.2% of Adagio Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Nihon Kohden beats Adagio Medical on 8 of the 14 factors compared between the two stocks.

About Adagio Medical

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.

About Nihon Kohden

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers. The company also provides medical support system, which includes diagnostic and clinical information system; and in-vitro diagnostic equipment comprising hematology and clinical chemistry analyzers. In addition, it operates insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.